A DRUG for epilepsy sufferers is being recalled after it was found that some patients were getting uneven doses of the medicine, the European Medicines Agency said.
By The Newsroom
Published 22nd Jul 2011, 22:27 BST
Updated 23rd Jul 2011, 00:03 BST
Doctors across Europe have been asked to give their patients an alternative to Vimpat 15mg/ml syrup - which is used as an addition to other anti-epilepsy medications for better control of partial-onset seizures.